Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've been sitting with a Wegovy prescription for a week and still haven't opened the box, that's more common than you'd think. The worry is real: needles, side effects, whether it will even work. Wegovy (semaglutide) is a prescription-only weight-management injection reviewed by a clinician before it's dispensed — so by the time it reaches you, someone has already judged it suitable. This page is for the bit between prescription and first injection: the hesitation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've read the leaflet. Maybe twice. You know the pen is in the fridge and the appointment with yourself keeps getting postponed. The fear tends to cluster around two things: the needle, and the unknown. Both are understandable, and both are worth taking seriously rather than brushing off.
On the needle: Wegovy pens use a fine, short needle that goes under the skin, subcutaneous, not into muscle. Our prescribers hear, almost weekly, that people expected something closer to a blood test and were surprised by how little they felt. The pen is designed to be used without seeing the needle at all; you press it against the skin, press the button, and that's the mechanism. You can't get that wrong.
On the unknown: you don't know how your body will respond, and no one can promise you a frictionless first few weeks. What the clinical evidence does show (from the STEP 1 trial, published in the New England Journal of Medicine) is that the dose titration sequence is built precisely to reduce early discomfort. The 0.25 mg starting dose exists to settle your system gently, not to produce weight loss from week one. That context changes the framing: early nausea, if it comes, is a sign the schedule is working as designed, not a signal that something is wrong.
One checking habit worth doing right now: look at the pen in your hand and confirm the liquid is clear and colourless, and if you want to understand exactly what a correctly prepared pen should look like before you use it, our guide to the Wegovy golden shot walks you through what to expect. That takes under a minute and means you're already engaged with it rather than avoiding it.
Nausea tops the list of early concerns, and it's the honest answer that it does affect some people, particularly after the first injection or after stepping up to a new dose. For most, it's a background feeling rather than the dramatic version they feared, present in the hours after the injection, often gone by the next morning. Eating smaller portions and avoiding rich or fatty meals in the days after each injection tends to reduce it noticeably.
Other things that come up: constipation, some people; diarrhoea, others; indigestion, tiredness in the first week or two. The NHS patient information for semaglutide covers these in full and is worth reading alongside your Patient Information Leaflet rather than instead of it.
What tends to surprise people is that by week three or four, most of the early GI discomfort has quietened significantly. The body adapts. The side effects that feel most alarming on paper are usually mild and transient in practice. That said: severe, persistent stomach pain (especially if it reaches the back) needs urgent medical attention and should not be waited out. Gallbladder symptoms are another reason to get checked quickly. Neither of these is common, but both matter.
If you've read about the fears around taking Wegovy more broadly, you'll know that most people who stop early do so in the first four weeks. Getting through that window with good support changes outcomes.
Week one: you inject 0.25 mg. You may feel nothing beyond mild queasiness for a day. You may feel completely fine. Appetite starts to shift for some people here, but the dose isn't designed for meaningful weight loss yet, it's designed to let your gut receptors adjust to semaglutide without a sharp reaction.
Weeks five to eight: the dose steps to 0.5 mg, then continues upward every four weeks, guided by your prescriber. This isn't a race. The titration exists because people who move through it slowly report better tolerability and, ultimately, better adherence. Adherence is what produces results.
The full guide to starting Wegovy covers injection technique, timing and what to track in your first weeks. If you're weighing up whether the timing is right for you, this page on when to begin talks through practical considerations including travel, busy periods and how to handle the first dose around your schedule.
For those thinking about how Wegovy compares to other treatment options, our semaglutide overview sets out the full clinical picture in one place. And if cost has been part of the hesitation, the Wegovy cost page explains what's included in a private prescription and what the price covers.
Fear sometimes attaches not just to the medicine itself but to the process of getting it, particularly if someone has looked online and found sellers offering it without a clinical assessment. The MHRA has warned explicitly about counterfeit and illegally-traded weight-loss pens, some of which have contained dangerous substances. The only legal route to Wegovy in the UK is a prescription following clinical review.
At nume, every consultation is read personally by a GPhC-registered Independent Prescriber on the same day, a real clinician, not software, working through your answers. If you're approved, treatment is dispatched the same day for free next-working-day delivery by DPD, in plain packaging. You can verify our pharmacy on the GPhC register at registration number 9012878. Aftercare is available seven days a week, so if your first injection raises questions, there's someone to ask.
If you're ready to take that first step, check your eligibility with a free consultation and let our prescribers take it from there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.